NCT07103174View on ClinicalTrials.gov

A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 16, 2025

Primary Completion Date

July 16, 2027

Study Completion Date

December 16, 2027

Conditions
Atopic Dermatitis (AD)
Interventions
BIOLOGICAL

MG-K10 placebo

Administer the drug once every 4 weeks for a total of 6 times

Trial Locations (2)

201203

Tower 5,No.34,Chunxiao Road No.122 Pudong District, Shanghai, 201203.p R. china, Shanghai

310000

Hangzhou First People's Hospital, Zhejiang

All Listed Sponsors
lead

Shanghai Mabgeek Biotech.Co.Ltd

OTHER_GOV